BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Hemophilia Alliance - ECPv6.3.7//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Hemophilia Alliance
X-ORIGINAL-URL:https://hemoalliance.org
X-WR-CALDESC:Events for Hemophilia Alliance
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231127T130000
DTEND;TZID=America/New_York:20231127T140000
DTSTAMP:20260406T044212
CREATED:20231031T175111Z
LAST-MODIFIED:20231031T175452Z
UID:45934-1701090000-1701093600@hemoalliance.org
SUMMARY:🟥 Member Webinar : Hemophilia Alliance Hosts - A webinar from HEMA Biologics - A different treatment option for Inhibitor patients
DESCRIPTION:Date: Monday\, November 27\, 2023\nTime: 1:00pm – 2:00pm ET \n\n \nTITLE:\nA different treatment option for Inhibitor patients \nOBJECTIVE:\nThis presentation will provide an overview of inhibitors and explore the efficacy\, safety\, tolerability\, clinical development\, and reasons to consider a different treatment option. \nTARGET AUDIENCE:\nAll HTC Staff \nSPEAKER:\n\nGuy Young\, MD. \nDirector\, Hemostasis and Thrombosis Center\nDirector\, Clinical Coagulation Laboratory Cancer and Blood Disorders Institute Children’s Hospital Los Angeles\nProfessor of Pediatrics\, University of Southern California Keck School of Medicine
URL:https://hemoalliance.org/alliance-events/a-webinar-from-hemabiologics-a-different-treatment-option-for-inhibitor-patients/
CATEGORIES:Members Only,Webinar
END:VEVENT
END:VCALENDAR